In this episode of the Habits ... He is the Founder of Concierge MD Los Angeles, a full-service concierge medical practice in Los Angeles that focuses on medical house calls for primary and ...

Ketamine can trigger symptoms similar to those of schizophrenia, but it isn’t known to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other ...

As the Washington Post reports, 36-year-old DOGE lackey Alexandra Beynon previously spent her days as head of engineering at the online ketamine therapy ... back the White House, federal workers ...

So could ketamine be Gen Z's drug of choice ... in a setting familiar to most teens - a house party. "I felt like I was walking on the moon," she says. "I remember vividly walking up the stairs ...

Recreational ketamine use has increased in the United ... and identified those respondents who had a major depressive episode within the previous year. According to the survey data, people ages ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Before rehabilitation (left), Casey Innalls was using ketamine every day Every generation ... in a setting familiar to most teens - a house party. "I felt like I was walking on the moon," she ...

SINGAPORE – Ketamine, the controlled drug best known as a horse tranquilliser or party supplement, has in the last four years become a boon to scores of severely depressed patients in Singapore.

Spravato, which is derived from ketamine, is not a new drug—it first came on the market in 2019. The spray was previously approved as a companion treatment to an oral antidepressant, as well as ...